US Patent Issued to BIONTECH RNA PHARMACEUTICALS, TRON-Translationale Onkologie An Der Universitatsmedizin Der Johannes Gutenberg-Universitat Mainz Gemeinnutzige on May 6 for "RNA replicon for reprogramming somatic cells" (German Inventors)

ALEXANDRIA, Va., June 10 -- United States Patent no. 12,291,717, issued on May 6, was assigned to BIONTECH RNA PHARMACEUTICALS GMBH (Mainz, Germany) and TRON-Translationale Onkologie An Der Universitatsmedizin Der Johannes Gutenberg-Universitat Mainz Gemeinnutzige GMBH (Mainz, Germany).

"RNA replicon for reprogramming somatic cells" was invented by Marco Alexander Poleganov (Mainz, Germany), Mario Perkovic (Mainz, Germany), Ugur Sahin (Mainz, Germany) and Tim Beissert (Mainz, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention embraces a RNA replicon that can be replicated by a replicase of alphavirus origin and comprises an open reading frame encoding a reprogramming factor. Such RN...